CVS Health (CVS.US) stock fell 5% despite the fact that the drugstore chain reported upbeat quarterly figures. Company earned $1.30 per share, well above market expectations of $1.24 per share. Revenue came in at $69.55 billion, compared with $68.75 billion expected as prescription volume lifted sales and the drugstore chain attracted new customers with Covid-19 testing and vaccines. However the company warned that the current quarter will be its lowest earnings quarter for the year because of the weaker flu season and investments to its Covid vaccine program.

DE40: Europan market still under pressure of weak industry and political turmoil
Daily summary: US100 surges almost 1% 📈Crypto and precious metals on the rise
Stock of the Month: Will Meta win the AI race?
AMD rises on the wave of the OpenAI deal. Pre-market trading shows a 25% increase in shares.